Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Senores Pharmaceuticals IPO listing
Senores Pharmaceuticals IPO listing date today. GMP, experts signal up to 70% gain for share allottees
According to market observers, the grey market is expecting that Senores Pharmaceuticals IPO listing price would be around ₹676
Senores Pharmaceuticals share price, IPO listing highlights:The IPO debuts with strong premium but shares end in red
The stock ended at ₹562 on the NSE, down ₹38 or 6.33%, and at ₹557.80 on the BSE, down ₹35.90 or 6.05%. During the day, the stock touched a 52-week high of ₹609.65 and a low of ₹538.85. Despite the dip,
Senores Pharmaceuticals Share Price, IPO Listing Highlights: IPO lists at 53% premium, stock closes 6.3% lower
Senores Pharmaceuticals Share Price, IPO Listing Live Updates: Senores Pharma IPO debuts Dec 30, oversubscribed 97.86x. Check listing price, GMP, and allotment now!
Senores Pharmaceuticals Share Price Highlights: Stock ends 6% below listing price but 43% above IPO price
Senores Pharmaceuticals shares listed at 53% premium on NSE and 52% premium on BSE. Following the bumper debut, the stock witnessed some profit taking at higher levels.
Senores Pharmaceuticals IPO allotment today: Key details investors need to know
The basis of allotment for Senores Pharmaceuticals IPO shares is set to be finalised on Thursday, December 26, 2024. Investors who subscribed to the public offering can check their allotment status on the official websites of BSE,
Senores Pharmaceuticals IPO Vs Ventive Hospitality IPO: Which issue will list with higher gains?
Compare Senores Pharma and Ventive IPOs for potential listing gains. Discover which could deliver better returns!
Senores Pharmaceuticals IPO Day 3 Highlights: Issue booked 93.41 times on third day; check GMP & other details
The Senores Pharmaceuticals' public issue will close for public bidding on Tuesday, December 24. The IPO has received 13.93x subscription on Day 2.
Senores Pharmaceuticals IPO listing bonanza: shares debut at 53% premium, pare gains at close
Ahmedabad-based Senores Pharmaceuticals raised Rs 582.11 crore through its IPO, which comprised a fresh issue of Rs 500 crore and an offer-for-sale of Rs 82.11 crore.
Senores Pharmaceuticals Lists At Premium Of 53% Over IPO Price
The Rs 582.1-crore Senores Pharmaceuticals offering consists of a fresh issue of Rs 500 crore and an offer for sale of Rs 82.1 crore.
Senores Pharmaceuticals Listing: Shares debut strong with 53% premium over IPO price
The issue had opened for public subscription on December 20 to raise about ₹582 crore from the primary market.
ET Now on MSN
7d
Senores Pharmaceuticals IPO GMP today; allotment status date and time - check online guide, tutorial
Senores Pharmaceuticals IPO subscription status Senores Pharmaceuticals fetched 51.13 times subscriptions on the final day of ...
ndtvprofit
10d
Senores Pharmaceuticals IPO Subscribed 13.9 Times On Day 2; Check GMP, Price Band And More
The grey market premium of Senores Pharmaceuticals was Rs 220 as of 4:28 p.m. on Monday, according to Chittorgarh's unit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
FBI: Attacker acted alone
Russian drone strike on Kyiv
Home searched amid probe
Broccoli recalled
Oldest Olympic champ dies
Winter storm warnings
How to watch Quadrantids
Sugar Bowl postponed
Pulls out of Glastonbury
'General Hospital’ actor dies
Tesla Cybertruck explosion
New rules for next Congress
Queens nightclub shooting
Quake strikes Lake County
Homemade bombs in Va.
Texas wins Peach Bowl
New NC gov. sworn in
2025 Pro Bowl rosters
Israeli airstrikes in Gaza
Weekly jobless claims fall
Montenegro mass shooting
China hacks sanctions office
Puerto Rico power restored
Russian gas to Europe halted
Hawaii fireworks explosion
New Orleans terror attack
Preinaugural rally in DC
Baldoni files $250M lawsuit
Pearl Harbor survivor dies
Commutes death sentences
Feedback